Is MK Proteins a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that MK Proteins Ltd is a below average quality company .

Is MK Proteins undervalued or overvalued?

The key valuation ratios of MK Proteins Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is MK Proteins share price return in the past 10 years?

Data is not available for this company

Is MK Proteins a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of MK Proteins Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

MK Proteins Ltd - Stock Valuation and Financial Performance

Name: MK Proteins
Brand: MK Proteins

BSE: 543919 | NSE: MKPL | Edible Oil | Small Cap

Place order

MK Proteins Share Price

₹12.90 -0.12 -0.92%
as on 31-May'24 16:01

DeciZen - make an informed investing decision on MK Proteins

Based on:

Data

Overall Rating ⓘ
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

3. Price Trend

MK Proteins stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

45.48

Market Cap:

484.2 Cr.

52-wk low:

9.6

52-wk high:

33.3

Is MK Proteins Ltd an attractive stock to invest in?

10 Year X-Ray of MK Proteins: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	7%	9.4%	9.5%	8.1%	7.1%	6%	6.1%	21.1%	16.5%	13.8%	-
Value Creation Index ⓘ	-0.5	-0.3	-0.3	-0.4	-0.5	-0.6	-0.6	0.5	0.2	0.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	122	123	145	165	172	157	194	311	256	315	315
Sales YoY Gr.	-	1.2%	17.5%	13.7%	4.3%	-8.7%	23.8%	60.3%	-17.8%	23.1%	-
Adj EPS ⓘ	0	0	0	0	0	0	0.1	0.3	0.3	0.3	0.3
YoY Gr.	-	50%	0%	33.3%	0%	0%	25%	460%	-3.6%	3.7%	-
BVPS (₹) ⓘ	0.1	0.1	0.1	0.2	0.4	0.5	0.5	0.8	1.1	1.3	2.2
Adj Net Profit ⓘ	0.5	0.8	0.8	1	1.4	1.6	1.8	10.4	10.2	10.6	11
Cash Flow from Ops. ⓘ	-5.3	10.9	-4.2	-3.6	-12	6.4	-4.5	5.5	-10.1	-7.7	-
Debt/CF from Ops. ⓘ	-5.3	1.8	-6.2	-8.6	-2.7	4.1	-6.8	4.5	-3.6	-5.8	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	11.1%	12.9%	17.5%	23.1%
Adj EPS ⓘ	34.1%	47.6%	77.6%	3.7%
BVPSⓘ	38.8%	26.7%	38.9%	26.4%
Share Price	-	-29.3%	-45.4%	-98.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	33.9	39.4	28.5	26.9	14.2	10	9.9	43	29.5	23.5	16.1
Op. Profit Mgn % ⓘ	2.3	3.4	3	3.1	3.2	3.2	2.5	5.1	6.1	5.4	5.2
Net Profit Mgn % ⓘ	0.4	0.7	0.6	0.6	0.8	1.1	0.9	3.3	4	3.4	3.3
Debt to Equity ⓘ	16.4	7.8	8	7.7	2.1	1.5	1.6	0.9	0.9	0.9	-
Working Cap Days ⓘ	64	81	76	78	95	108	90	69	105	107	142
Cash Conv. Cycle ⓘ	57	57	47	59	76	93	78	55	89	91	110

Recent Performance Summary

Latest Financials - MK Proteins Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.3	-
TTM Sales (₹ Cr.)	315	-
BVPS (₹.) ⓘ	2.2	-
Reserves (₹ Cr.) ⓘ	43	-
P/BV ⓘ	6.00	-
PE ⓘ	45.48	-

From the Market
52 Week Low / High (₹)	9.60 / 33.33
All Time Low / High (₹)	9.60 / 33.33
Market Cap (₹ Cr.)	484
Equity (₹ Cr.)	37.5
Face Value (₹)	1
Industry PE ⓘ	80.1

Management X-Ray of MK Proteins:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of MK Proteins

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of MK Proteins

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	122	123	145	165	172	157	194	311	256	315
Operating Expenses ⓘ	119	119	141	160	166	152	189	295	240	298
Manufacturing Costs	5	4	8	10	6	6	7	7	10	9
Material Costs	112	113	130	146	158	144	180	286	227	285
Employee Cost	1	1	1	1	2	2	1	1	2	1
Other Costs ⓘ	1	1	1	1	1	1	1	1	1	2
Operating Profit ⓘ	3	4	4	5	6	5	5	16	16	17
Operating Profit Margin (%)	2.3%	3.4%	2.9%	3.0%	3.2%	3.2%	2.5%	5.1%	6.1%	5.4%
Other Income ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	2	2	2	2	2	2	1	1	2
Depreciation ⓘ	0	1	1	1	1	1	1	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	1	1	1	2	2	2	2	14	14	15
Tax ⓘ	0	0	0	1	1	1	1	4	4	4
Profit After Tax	0	1	1	1	1	2	2	10	10	11
PAT Margin (%)	0.4%	0.7%	0.5%	0.6%	0.8%	1.0%	0.9%	3.3%	4.0%	3.4%
Adjusted EPS (₹)	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	2	3	3	4	15	17	19	29	40	50
Share Capital ⓘ	1	1	1	3	4	4	4	4	4	13
Reserves ⓘ	1	2	3	2	11	13	15	25	35	38
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	28	20	26	30	32	26	30	25	37	44
Long Term Debt	10	7	8	12	12	2	4	4	3	3
Short Term Debt	18	12	18	18	21	24	26	20	34	42
Trade Payables	2	12	8	9	5	2	4	8	5	5
Others Liabilities ⓘ	1	1	2	3	3	2	3	5	5	5
Total Liabilities ⓘ	32	35	39	47	56	47	56	67	86	105
Fixed Assets
Gross Block	4	8	9	10	10	4	3	10	11	11
Accumulated Depreciation	1	1	2	3	5	0	0	7	8	9
Net Fixed Assetsⓘ	3	6	7	7	6	4	3	2	3	2
CWIP ⓘ	3	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	19	22	20	33	30	29	39	38	50	71
Trade Receivables	6	5	11	5	19	11	10	21	29	16
Cash Equivalents	0	0	0	0	0	0	0	0	0	0
Others Assetsⓘ	1	2	1	2	2	3	5	6	4	15
Total Assets ⓘ	32	35	39	47	56	47	56	67	86	105

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	-5	11	-4	-4	-12	6	-4	6	-10	-8
PBT ⓘ	1	1	1	2	2	2	2	14	14	15
Adjustment ⓘ	2	3	3	3	3	3	3	2	2	2
Changes in Working Capital ⓘ	-8	7	-6	-6	-15	4	-7	-8	-21	-18
Tax Paid ⓘ	0	0	0	0	-1	-1	-1	-1	-4	-5
Cash Flow From Investing Activity ⓘ	-3	0	-2	-1	0	0	0	0	-2	0
Capex	-3	-1	-2	-1	0	0	0	0	-2	0
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	8	-10	6	5	12	-7	4	-5	12	8
Net Proceeds from Shares ⓘ	0	0	0	0	10	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	5	-3	1	4	2	-13	2	1	-2	0
Interest Paid ⓘ	-2	-2	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	5	-5	6	0	1	6	2	-6	14	8
Net Cash Flow ⓘ	0	0	0	0	0	0	0	0	0	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	33.94	39.43	24.9	27.1	14.62	10.07	10.07	43.03	29.54	23.69
ROCE (%)	10.06	13.53	13.06	11.82	10.57	8.42	8.54	29.13	22.82	19.15
Asset Turnover Ratio	4.56	3.66	3.9	3.85	3.35	3.04	3.75	5.04	3.35	3.31
PAT to CFO Conversion(x)	N/A	11	-4	-4	-12	3	-2	0.6	-1	-0.73
Working Capital Days
Receivable Days	20	17	20	17	25	34	19	18	36	26
Inventory Days	41	60	53	59	67	69	64	45	62	70
Payable Days	5	22	28	21	17	10	6	8	11	6

MK Proteins Ltd Stock News

MK Proteins Ltd FAQs

What is the share price of MK Proteins?

Company share prices are keep on changing according to the market conditions. The closing price of MK Proteins on 31-May-2024 16:01 is ₹12.90.

What is the market cap of MK Proteins?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-May-2024 16:01 the market cap of MK Proteins stood at ₹484.2.